Related Experiment Video
Updated: Dec 22, 2025
06:38
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.3K
Evolution of Systemic Therapy for Hepatocellular Carcinoma
Richard S Finn1, Andrew X Zhu2,3
1Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
Hepatology (Baltimore, Md.)
|May 8, 2020
Summary
Hepatocellular carcinoma (HCC) drug development is advancing, with immune-oncology showing promise. Future research will focus on patient selection and combination strategies for advanced HCC treatment.
Area of Science:
- Hepatocellular carcinoma (HCC) research
- Cancer drug development
- Immunotherapy in oncology
Background:
- Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality worldwide.
- Historically, HCC has lacked focus in novel drug development pipelines.
- Recent phase 3 studies have shown progress in advanced HCC treatment.
Purpose of the Study:
- To review the recent advancements in hepatocellular carcinoma (HCC) drug development.
- To highlight the growing importance of immune-oncology approaches in HCC.
- To identify future directions for clinical trials in advanced HCC.
Main Methods:
- Review of recent hallmark phase 3 studies in advanced HCC.
- Analysis of the role and potential of immune-oncology in HCC treatment.
- Discussion of challenges in patient selection and combination strategies.
Main Results:
- Significant progress has been made in developing novel therapies for advanced HCC.
- Immune-oncology approaches have emerged as a key area of interest.
- There is a recognized need for optimized patient selection and combination therapies.
Conclusions:
- Recent clinical studies mark a turning point for HCC drug development.
- Further research is needed to refine immune-oncology strategies and patient stratification.
- Translating tumor biology insights into clinical trial design is crucial for future progress.
Related Concept Videos
02:49Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
02:57Targeted Cancer Therapies
8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.5K
02:56Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
120
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
120
01:21Hepatic Portal System
4.7K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
4.7K
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K